Adnectin VEGFR/IGFR inhibitor (Adnexus/BMS)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAdnectin VEGFR/IGFR inhibitor (Adnexus/BMS)
Drug Alias NameVEGFR/IGFR modulator (Bristol-Myers Squibb/Adnexus)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionSomatomedin receptors antagonistsVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptorSomatomedin receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdnexus Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdnexus Therapeutics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A